Neoadjuvant Osimertinib With/Without Chemotherapy Versus Chemotherapy Alone for <i>EGFR</i> -Mutated Resectable Non-Small-Cell Lung Cancer: NeoADAURA

  • Masahiro Tsuboi
    National Cancer Center Hospital East, Kashiwa, Chiba277-8577, Japan
  • Walter Weder
    Thoraxchirurgie Klinik Bethanien, Zürich, 8044, Switzerland
  • Carles Escriu
    The Clatterbridge Cancer Centre, Bebington, Wirral, CH63 4JY, UK
  • Collin Blakely
    Department of Medicine, University of California, San Francisco, CA94158-2140, USA
  • Jianxing He
    The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong Province, China
  • Sanja Dacic
    Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA15213, USA
  • Yasushi Yatabe
    National Cancer Center, Chuo-ku, Tokyo104-0045, Japan
  • Lingmin Zeng
    AstraZeneca, Gaithersburg, MD20878, USA
  • Andrew Walding
    AstraZeneca, Alderley Park, SK10 4TF, UK
  • Jamie E Chaft
    Thoracic Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center & Weill Cornell Medical College, New York, NY10021, USA

収録刊行物

  • Future Oncology

    Future Oncology 17 (31), 4045-4055, 2021-07-19

    Informa UK Limited

被引用文献 (1)*注記

もっと見る

参考文献 (46)*注記

もっと見る

関連プロジェクト

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ